Accepted Manuscript Effectiveness of myofascial release: systematic review of randomized controlled trials M.S. Ajimsha, MPT, ADMFT, PhD Noora R. Al-Mudahka, PT, MBA J.A. Al-Madzhar, PT PII:
S1360-8592(14)00086-2
DOI:
10.1016/j.jbmt.2014.06.001
Reference:
YJBMT 1142
To appear in:
Journal of Bodywork & Movement Therapies
Received Date: 5 December 2013 Revised Date:
4 June 2014
Accepted Date: 6 June 2014
Please cite this article as: Ajimsha, M.S., Al-Mudahka, N.R., Al-Madzhar, J., Effectiveness of myofascial release: systematic review of randomized controlled trials, Journal of Bodywork & Movement Therapies (2014), doi: 10.1016/j.jbmt.2014.06.001. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
EFFECTIVENESS OF MYOFASCIAL RELEASE:
2
SYSTEMATIC REVIEW OF RANDOMIZED
3
CONTROLLED TRIALS
4 5 6
RI PT
1
M.S. Ajimsha, MPT, ADMFT, PhD a,*, Noora R. Al-Mudahka, PT, MBA a, AlMadzhar JA, PT a a
9
INTRODUCTION: Myofascial release (MFR) is a form of manual therapy that involves the
10
application of a low load, long duration stretch to the myofascial complex, intended to restore
11
optimal length, decrease pain, and improve function. Anecdotal evidence shows great promise for
12
MFR as a treatment for various conditions. However, research to support the anecdotal evidence is
13
lacking. OBJECTIVE: To critically analyze published randomized controlled trials (RCTs) to
14
determine the effectiveness of MFR as a treatment option for different conditions. DATA
15
SOURCES: Electronic databases: MEDLINE, CINAHL, Academic Search Premier, Cochrane
16
library, and Physiotherapy Evidence Database (PEDro), with key words myofascial release
17
and myofascial release therapy. No date limitations were applied to the searches. STUDY
18
SELECTION: Articles were selected based upon the use of the term myofascial release in the
19
abstract or key words. The final selection was made by applying the inclusion and exclusion criteria
20
to the full text. Studies were included if they were English-language, peer-reviewed RCTs on MFR
21
for various conditions and pain. DATA EXTRACTION: Data collected were number of
22
participants, condition being treated, treatment used, control group, outcome measures and results.
23
Studies were analyzed using the PEDro scale and the Center for Evidence-Based Medicine's Levels
24
of Evidence scale. CONCLUSIONS: The literature regarding the effectiveness of MFR was mixed
AC C
EP
TE D
M AN U
Department of Physiotherapy, Hamad Medical Corporation, Doha, Qatar
SC
7 8
1
ACCEPTED MANUSCRIPT in both quality and results. Although the quality of the RCT studies varied greatly, the result of the
26
studies was encouraging, particularly with the recently published studies. MFR is emerging as a
27
strategy with a solid evidence base and tremendous potential. The studies in this review may help as
28
a respectable base for the future trials. KEY WORDS: myofascial release, myofascial release
29
therapy
RI PT
25
30 * Corresponding author. Tel.: +974 55021106.
32
E-mail address:
[email protected] (M.S. Ajimsha).
SC
31
33
INTRODUCTION
35
Myofascial release (MFR) is a widely employed manual therapy treatment that involves specifically
36
guided low load, long duration mechanical forces to manipulate the myofascial complex, intended to
37
restore optimal length, decrease pain, and improve function (Barnes., 1990). MFR when used in
38
conjunction with conventional treatment is said to be effective to provide immediate relief of pain
39
and tissue tenderness (Hou et al., 2002, McKenney et al., 2013). It has been hypothesized that fascial
40
restrictions in one region of the body cause undue stress in other regions of the body due to fascial
41
continuity. This may result in stress on any structures that are enveloped, divided, or supported by
42
fascia (Schleip., 2003). Myofascial practitioners claim that by restoring the length and health of
43
restricted connective tissue, pressure can be relieved on pain sensitive structures such as nerves and
44
blood vessels.
45
MFR generally involves slow, sustained pressure (120-300 s) applied to restricted fascial layers
46
either directly (direct MFR technique) or indirectly (indirect MFR technique). Direct MFR technique
47
is thought to work directly over the restricted fascia: practitioners use knuckles or elbow or other
48
tools to slowly sink into the fascia, and the pressure applied is a few kilograms of force to contact the
49
restricted fascia, apply tension, or stretch the fascia. Indirect MFR involves a gentle stretch guided
AC C
EP
TE D
M AN U
34
2
ACCEPTED MANUSCRIPT along the path of least resistance until free movement is achieved (GOT, 2009). The pressure applied is a
51
few grams of force, and the hands tend to follow the direction of fascial restrictions, hold the stretch,
52
and allow the fascia to loosen itself (Ajimsha et al., 2013) The rationale for these techniques can be
53
traced to various studies that investigated plastic, viscoelastic, and piezoelectric properties of
54
connective tissue (Schleip., 2003,2012; Pischinger., 1991; Greenman., 2003).
55
Recent Fascia Research Congresses (FRC) define fascia as a ‘soft tissue component of the
56
connective tissue system that permeates the human body’ (Huijing and Langevin, 2009). One could
57
also describe them as fibrous collagenous tissues that are part of a body-wide tensional force
58
transmission system (Schleip R et al., 2012). The complete fascial net includes dense planar tissue
59
sheets, ligaments, tendons, superficial fascia and even the innermost intramuscular layer of the
60
endomysium. The term fascia now includes the dura mater, the periosteum, perineurium, the fibrous
61
capsular layer of vertebral discs, organ capsules as well as bronchial connective tissue and the
62
mesentery of the abdomen (Schleip R et al., 2012). Fascial tissues are seen as one interconnected
63
tensional network that adapts its fiber arrangement and density, according to local tensional demands
64
(Schleip R et al., 2012).
65
Authors such as Day (2009), Stecco (2013) and Langevin (2011) and colleagues, have suggested
66
that connective tissue could become tighter/denser in overuse syndromes, or after traumatic injuries,
67
but it is unclear if this is due to an alteration of collagen fiber composition, of fibroblasts, or of
68
ground substance. The same authors suggest that the alteration of fascial pliability could be a source
69
of body misalignment, potentially leading to poor muscular biomechanics, altered structural
70
alignment, and decreased strength and motor coordination. MFR practitioners claim to be clinically
71
efficacious in providing immediate pain relief and to improve physiologic functions that have been
72
altered by somatic dysfunctions (Hou et al., 2002, McKenney et al., 2013). MFR directs force to
73
fascial fibroblasts, as well as indirect strains applied to nerves, blood vessels, the lymphatic system,
74
and muscles. Laboratory experiments suggest that fibroblasts, the primary cell type of the fascia,
AC C
EP
TE D
M AN U
SC
RI PT
50
3
ACCEPTED MANUSCRIPT 75
adapt specifically to mechanical loading in manners dependent upon the strain magnitude, duration
76
and frequency. Meltzer et al (2010), in their in-vitro modeling study demonstrated that treatment
77
with MFR, after repetitive strain injury, resulted in normalization of apoptotic rate, and reduction in
78
production of inflammatory cytokines.
RI PT
79
MFR is being used to treat patients with a wide variety of conditions, but there is little research to
81
support its efficacy. According to Kidd (2009) the application of MFR is inherently not evidence-
82
based medicine since it relies on clinician-patient interaction, it cannot be a neutral treatment;
83
therefore, the subjectivity of the interaction cannot be removed when we try to determine its
84
outcome. Kidd indicated that much of the effect of MFR relies on the skill of the clinician and his or
85
her ability to sense the changes in the tissue. In addition, biological effects of touch can change the
86
effectiveness of the treatment, depending on the state of either the clinician or the patient. This
87
variability means that interrater reliability is low, and therefore, according to Kidd, prevents MFR
88
from being considered evidence-based. Yet the same arguments have been applied to other manual
89
therapies in the past that now are considered part of evidence-based practice. Although MFR is a
90
popular therapy and anecdotal reports describe positive outcomes from MFR treatments, research is
91
necessary to demonstrate its effectiveness to refute Kidd’s argument. Therefore, the purpose of this
92
systematic review was to critically analyze previously published literatures of RCTs to gather the
93
documented effectiveness of MFR.
M AN U
TE D
EP
AC C
94
SC
80
95
METHODS
96
We searched the following electronic databases with no date limitations: MEDLINE, CINAHL,
97
Academic Search Premier, Cochrane library, and Physiotherapy Evidence Database (PEDro) by
98
adhering to the systemic review process followed by McKenney et al (2013) in their study. Two
99
reviewers performed independent searches in September 2013 which was later updated in May 2014. 4
ACCEPTED MANUSCRIPT Key words used for the search were myofascial release and myofascial release therapy. Each
101
reviewer identified articles as relevant based on the use of the term myofascial release in the abstract
102
or key words. The lists were compared, and articles identified by both reviewers were collected in
103
full text. A total of 133 articles were identified as relevant by both reviewers.
104
The 2 experienced reviewers with sound knowledge in the PEDro and CEBM’s scales, screened the
105
full-text articles for inclusion based on a set of inclusion and exclusion criteria. The inclusion criteria
106
were as follows: (1) RCTs published in a scientific peer-reviewed journal, (2) studies with 10 or
107
more participants, (3) contained sufficient information to complete an analysis, (4) used indirect and
108
passive MFR as an experimental treatment, (5) published in English, (6) studied human participants,
109
and (7) included adult participants only (18 years and older). Articles were excluded if published as
110
case studies, editorials, expert opinions, or instructive articles; used trigger point therapy; or did not
111
use MFR as defined. Studies on myofascial trigger-point therapy, proprioceptive neuromuscular
112
facilitation (PNF) and MFR used as a conventional treatment without distinct explanations were also
113
excluded. Subsequently, 19 articles met the criteria for inclusion in our analysis.
114
Next, the reviewers assessed all studies meeting the inclusion criteria using 2 scales: the PEDro scale
115
(2012) (Table 1) and the Centre for Evidence-Based Medicine’s (CEBM’s) Levels of Evidence scale
116
(Phillips et al., 2009) (Table 2). The PEDro scale assesses methodological quality and consists of a
117
checklist of 11 criteria, 10 of which are scored. For each criterion the study met, 1 point was
118
awarded. The points were tallied and presented as a score out of 10. The scale applies only to
119
experimental studies. For this review, investigations with PEDro scores of 6 to 10 were considered
120
high quality, of 4 to 5 were considered moderate quality, and of 0 to 3 were considered low quality.
121
The PEDro scale does not evaluate clinical usefulness. The CEBM Levels of Evidence scale assesses
122
quality based on study design, which categorize the studies in a scale ranging from 1 to 5 with
123
further subdivision for each.
AC C
EP
TE D
M AN U
SC
RI PT
100
5
ACCEPTED MANUSCRIPT Systemic reviews with homogeneity of RCTs are ranked in the highest levels while expert opinions
125
rank the least (Table 2). In both scales, RCTs receives higher rankings, particularly with long-term
126
follow-up and narrow confidence intervals. The reviewers solved any rating discrepancies through
127
verbal discussion. A consensus was reached regarding all studies during the first meeting, which
128
were documented in the review process.
RI PT
124
129
RESULTS
131
Of the 133 studies identified in the original search, 19 were eligible as per the inclusion criteria
132
(Figure 1). The PEDro scores of the studies ranged from 5 of 10 to 8 of 10. Five studies rated as 1b
133
and 14 studies as 2b in the CEBM ratings. The most common reason for a 2b rank was that the study
134
had a small sample size and/or no long-term follow-up to treatment. The key characteristics and
135
methodological details are provided in Table 3.
136
Data Synthesis
137
The quality of research on MFR as a treatment varies widely. The recent published studies are
138
appreciable in their adherence to near normal RCT guidelines. Of the 19 studies included in our
139
analysis, we ranked the 5 RCTs at levels 1b and 14 at level 2b on the CEBM scale, indicating a
140
relatively high quality study design. Scores on the PEDro scale indicated moderate- to high-quality
141
study designs. The lowest score was 5 of 10 and the highest was 8 of 10.
AC C
EP
TE D
M AN U
SC
130
142
Hanten and Chandler (1994) conducted a moderate-quality study that was rated at level 2b on
143
the CEBM scale and 6 of 10 on the PEDro scale. The purpose of the study was to compare the effect
144
of MFR and PNF in increasing the straight leg raise (SLR) in the management of hamstring
145
tightness. The study highlighted the point that, though MFR is effective in increasing the SLR angle
146
against a control group receiving no treatment, the effect is inferior to a PNF treatment. The study
147
itself had positive outcomes (see Table 3), but it lacked random selection of participants and follow-
148
up. 6
ACCEPTED MANUSCRIPT The study by Barnes et al (1997) on pelvic symmetry was ranked as level 2b and earned a
150
PEDro score of 8 of 10. Overall, it was a high quality study; however, a few concerns lowered the
151
CEBM ranking, including the small sample size and the lack of follow-up. Only 10 participants were
152
involved, and the authors acknowledged that 23 participants were needed in the treatment group and
153
15 in the control group to meet the assumptions for parametric data analysis. Overly, the follow-up
154
measurements were conducted immediately after the treatment. Despite these limitations, the 8 of 10
155
ranking on the PEDro scale indicated that the study was well designed.
RI PT
149
Hsieh et al (2002) investigated the relative effectiveness of three manual treatments including
157
MFR for patients with subacute low back pain (SALBP). The study was rated as a high-quality one,
158
ranked at level 1b on the CEBM scale and earned 7 of 10 points on the PEDro scale. The 1b rating
159
reflects a study that was well designed, with a sufficient number of participants and adequate long-
160
term follow-up. The PEDro score indicates that the study design was strong. The back pain improved
161
in all groups, but there were no differences between the groups. Because the Hsieh et al study was
162
high quality, the results are relevant to use of MFR as an adjunct to a formal treatment for SALBP.
TE D
M AN U
SC
156
Another level 2b study was performed by Kuhar et al (2007), who used MFR to treat plantar
164
fasciitis. This study scored 7 of 10 points on the PEDro scale. Patients were evaluated at the
165
beginning of the treatment and then once more on the final day of treatment. However, no
166
measurements were taken as follow up, which lessened the study quality to level 2 on the CEBM
167
scale. As a result, we know only the immediate effects of MFR and cannot comment on long-term
168
effectiveness. Significant reduction in pain and improvement in foot function was reported as the
169
short term effect.
AC C
EP
163
170
Arroyo-Morales et al (2008) in their RCT studied the effects of MFR after high-intensity
171
exercise, which scored level 2b in CEBM scale with a quality of 6/10 in PEDro scale. The study
172
included 62 healthy, active individuals. After baseline measurements, the subjects performed
173
standardized warm-up exercises followed by three 30-second Wingate tests. After completing the 7
ACCEPTED MANUSCRIPT exercise protocol, the subjects were randomly assigned to MFR or a placebo group for a 40-minute
175
recovery period. Holter recording and BP measurements were taken after exercise protocol and after
176
the intervention and found that MFR favors the recovery of heart rate variability and diastolic BP
177
after high-intensity exercise to pre exercise levels. Short duration and lack of follow up along with
178
normal, healthy individual were considered as the limitation of the study with an assumption that
179
high-level sports people might possibly show a different behavior which makes the study into the 2b
180
level.
RI PT
174
SC
181
Tozzi, P et al (2011) studied pain perception and the mobility of fascial layers by using a
183
dynamic ultrasound (US) in patients with neck pain (NP) and low back pain (LBP). Sixty patients
184
with nonspecific neck pain and 60 with nonspecific back pain were divided into experimental and
185
control groups who were evaluated in the area of complaint, by ‘Dynamic US Topographic Anatomy
186
Evaluation’, before and after MFR were applied in situ, in the corresponding painful region, for not
187
more than 12 minute. The effects were compared with those from the respective sham control group
188
of 60 cases. The result highlighted that MFR can be effective in releasing area of impaired sliding
189
fascial mobility, and to improve pain perception over a short term duration in people with non-
190
specific NP or LBP. The study obtained 2b level evidence with a quality of 7/10. The study is
191
important because it suggested that ‘dynamic US evaluation’ can be a valid and non-invasive
192
instrument to assess effective sliding motion of fascial layers in vivo. Main limitations noted were
193
that pain assessment was for a short period of time following treatment and on a relatively small
194
study population without a follow up.
AC C
EP
TE D
M AN U
182
195 196
A study with 30 chronic myogenous temporo mandibular disorder (TMD) patients by
197
Kalamir et al (2010) investigated the effectiveness of intra-oral MFR therapy (IMT) by randomizing
198
into three groups; IMT, IMT plus ‘self-care’ and a wait list control with pain and ROM as the 8
ACCEPTED MANUSCRIPT 199
primary outcome measures. The measurements were taken at baseline, 6 weeks post-treatment, and 6
200
months post-treatment. They concluded that IMT with or without self-care may be beneficial in
201
chronic TMD over the short-medium term and advocated a larger scale study over a longer term. The
202
study obtained high quality rating on the PEDro scale (8/10) and 2b rating in CEBM.
RI PT
203
Kain et al in 2011 compared an indirect tri-planar MFR technique and a hot pack for
205
increasing gleno-humeral joint range of motion on 31 healthy individuals. Both the hot pack
206
application and the MFR technique were found to be as efficacious in increasing passive range of
207
motion of the gleno-humeral articulation. The tri-planar MFR could be considered more effective as
208
an intervention in terms of time spent with a patient and the number of patients seen in a 20-min
209
period and lack of equipment needed for MFR compared to hot pack use. The speed of the MFR
210
technique and the lack of equipment would suggest that it is a more time efficient type of
211
intervention, provided the therapist is trained in this technique. Improper blinding, concealing and
212
follow-up grade the quality of the study as moderate (5/10 in PEDro) and level 2b in CEBM.
TE D
M AN U
SC
204
Castro-Sánchez et al conducted two (2010, 2011) high quality studies in fibromyalgia. Both
214
studies were rated as 7/10 in PEDro scale and 1b in CEBM due to their methodological standards.
215
The first one; was to determine whether MFR therapy can improve pain, anxiety, quality of sleep,
216
depression, and quality of life in patients with fibromyalgia. Seventy four fibromyalgia patients were
217
randomly assigned to MFR and placebo groups. The intervention period was 20 weeks. Pain,
218
anxiety, quality of sleep, depression, and quality of life were determined at baseline, after the last
219
treatment session, and at 1month and 6 months. Right away after treatment and at 1 month, anxiety
220
levels, quality of sleep, pain, and quality of life were improved in the experimental group over the
221
placebo group. Even so, at 6 months post intervention, there were only significant differences in the
222
quality of sleep index. They have documented the exclusion of 35 of the 231 eligible participants due
223
to incompatibility with their work schedules as their major limitation and commented that patients
AC C
EP
213
9
ACCEPTED MANUSCRIPT with less severe pain may have been able to improve more rapidly. The second study was with 86
225
fibromyalgia patients to find out the effect of a 20 week MFR on pain, physical function, and
226
postural stability over a placebo group. MFR improved pain, sensory, and affective dimensions
227
without change in postural stability. They concluded that MFR techniques can be a complementary
228
therapy for fibromyalgia syndrome. The authors attributed that lack of a postural stability test with a
229
higher level of difficulty might have an effect on the result. Lack of blinding of therapists and
230
patients and the absence of a ‘hands-on’ component in the sham treatment was another drawback.
231
They recommended further research to compare outcomes with other manual therapies.
SC
RI PT
224
232
A study by Ajimsha M S (2011) on 63 tension headache patients compared the direct MFR technique
234
and indirect MFR technique with a sham control receiving slow soft stroking. The study was of
235
moderate quality (6/10) on PEDro with 2b level of evidence. The techniques consisted of 24 sessions
236
per patient over 12 weeks with the difference in number of days with headache at baseline and post
237
test as the outcome measure. Patients in the direct MFR group, the indirect MFR group and the
238
control group reported a 59.2%, 54% and 13.3% reduction respectively in their headache frequency
239
in post test compared to the baseline. Lack of follow up, blinding of the therapists and the patient
240
were the major limitations of the study.
EP
TE D
M AN U
233
Two moderate to high quality studies were found on quality of life of breast cancer survivors
242
(BCS). The first study was by Fernández-Lao et al (2012) on the influence of patient attitude towards
243
massage on pressure pain sensitivity and immune system after application of MFR. Twenty BCS, in
244
a two week study, received MFR or control (special attention) intervention. Salivary flow rate,
245
immunoglobulin A concentrations & the attitude toward massage scale were the outcome measures.
246
MFR led to an immediate increase in salivary flow rate in BCS with cancer-related fatigue. The
247
authors suggested that the effect of MFR on immune function was modulated by a positive patient's
248
attitude toward massage. Lack of therapist blinding and follow ups were the main drawbacks of the
AC C
241
10
ACCEPTED MANUSCRIPT study. The authors acknowledged that alterations of stress response to cancer related fatigue could
250
reduce the ability of MFR in changing salivary cortisol concentrations and α-amylase activity and
251
placebo effect associated with hands-on techniques might have influenced the outcome.
252
The second study was conducted by Cantarero-Villanueva et al (2011). Seventy eight BCS
253
participated in effectiveness of core stability exercises and recovery MFR on fatigue with the Profile
254
of Mood State questionnaire as the main outcome measure. The experimental group received core
255
stability exercises & MFR while the control group received usual health care advices for a period of
256
8 weeks. Mood state, fatigue, trunk curls endurance, and leg strength were determined at baseline,
257
after the last treatment session, and at 6 months of follow up. The multimodal program with MFR
258
reduced fatigue, tension, depression, improved vigor & muscle strength. The study was of moderate
259
to high quality (7/10) with level 2b evidence. The main drawback was that the control group was
260
allowed to freely increase physical activity during the study. They reasoned that this possible bias
261
was controlled as the control group did not demonstrate substantial gains in physical activity during
262
the study.
TE D
M AN U
SC
RI PT
249
A comparative study was performed on the effectiveness of MFR and PT for venous
264
insufficiency in postmenopausal women by Ramos-González et al (2012), which is of high quality
265
(8/10) with a 2b level of evidence. Sixty five postmenopausal women with stage I or II venous
266
insufficiency were enrolled into two groups. The control and experimental group patients underwent
267
physical venous return therapy (kinesiotherapy) for a 10-week period, during which the experimental
268
group patients also received 20 sessions of MFR. Main outcome measures were blood pressure, cell
269
mass, intracellular water, basal metabolism, venous velocity, skin temperature, pain and quality of
270
life. The combination of MFR and kinesiotherapy improved the venous return, pain and quality of
271
life in postmenopausal women with venous insufficiency. Lack of follow up and non blinding of the
272
researchers were the primary limitations.
AC C
EP
263
273 11
ACCEPTED MANUSCRIPT Ajimsha et al (2012) in their study investigated whether MFR reduces the pain and functional
275
disability of lateral epicondylitis in comparison with a control group receiving sham ultrasound
276
therapy in computer professionals (N=68) for 12 sessions per client over 4 weeks with the Patient-
277
Rated Tennis Elbow Evaluation (PRTEE) as the main outcome measure. The study was of a
278
moderately high quality on the PEDro scale (7/10) with 1b- level in CBEM. The MFR group
279
performed better than the control group at weeks 4 and 12. Patients in the MFR and control groups
280
reported a 78.7% and 6.8% reduction, respectively, in their pain and functional disability in week 4
281
compared with that in week 1, which persisted as 63.1% in the follow-up at week 12 in the MFR
282
group. Lack of therapist blinding was the major limitation of the study. A slight improvement over
283
time occurred in the control group at week 4 and the authors are attributing this to a meaning
284
response.
285
A similar type of study was carried on by Khuman et al (2013) on a smaller sample size of chronic
286
lateral epicondylitis (CLE) subjects. Thirty CLE subjects were divided into MFR & conventional
287
physiotherapy (n=15) and conventional physiotherapy (n=15) groups. Numerical pain rated scale,
288
PRTEE and hand dynamometer were the outcome measures. They concluded that a 4 weeks MFR
289
program was effective in improving pain, functional performance and grip strength in CLE subjects
290
compared to the control group. Lack of follow up and improper blinding were the major limitations.
291
The study scored 2b level of evidence with a quality of 7/10.
SC
M AN U
TE D
EP
AC C
292
RI PT
274
293
Another study by Ajimsha et al (2014) on the effectiveness of MFR in the management of chronic
294
low back pain (CLBP) in nursing professionals falls under a high quality one with a PEDro score of
295
7/10 and CBEM level of 1b. The participants were nursing professionals (N = 80) with CLBP. The
296
aim was to investigate whether MFR when used as an adjunct to specific back exercises (SBE)
297
reduces pain and disability in CLBP in comparison with a control group receiving a sham MFR and
298
SBE among nursing professionals. The McGill Pain Questionnaire (MPQ) was employed to assess 12
ACCEPTED MANUSCRIPT subjective pain experience and Quebec Back Pain Disability Scale (QBPDS) was employed to
300
evaluate the disability associated with CLBP. The primary outcome measure was the difference in
301
MPQ and QBPDS scores between week 1 (pretest score), week 8 (posttest score), and follow-up at
302
week 12 after randomization. The patients in the MFR group reported a 53.3% diminution in their
303
pain and 29.7% decrease in functional disability as evidenced in the MPQ and QBPDS scores in
304
week 8, whereas patients in the control group reported a 26.1% and 9.8% decrease in their MPQ and
305
QBPDS scores in week 8, which persisted as a 43.6% reduction of pain and 22.7% reduction of
306
functional impairment in the follow-up at week 12 in the MFR group compared to the baseline. The
307
authors advocated examining other outcomes such as pain beliefs, mood, and quality of life in future
308
studies.
M AN U
SC
RI PT
299
309
Kuruma et al conducted a study (2013) on the effects of MFR and stretching technique on range of
311
motion (ROM) and reaction time (RT) with a medium quality procedure (5/10 PEDro) and 2b level
312
in CBEM. Forty healthy individuals were randomly allocated to four groups: MFR for quadriceps;
313
MFR for hamstrings; stretch for quadriceps; and controls. Active ROM was significantly increased in
314
the two MFR groups and the stretch group. Passive ROM was significantly increased by MFR in the
315
quadriceps and stretching groups. Premotor time was significantly reduced by MFR in the quadriceps
316
and hamstrings groups. Compared to controls, RT was significantly lower after the interventions in
317
the quadriceps and hamstrings groups. Lack of blinding, concealing and follow up were the main
318
limitations of the study.
319
A recent study by Ajimsha et al (2014) investigated whether MFR reduces the pain and functional
320
disabilities associated with plantar heel pain (PHP) in comparison with a control group receiving
321
sham ultrasound therapy. Sixty six PHP patients, in a 4 week study, received MFR or control
322
intervention. The study was a well designed and executed one, with sufficient number of participants
323
and adequate follow-up, ranked level 2b on the CEBM scale and scored 8/10 on the PEDro scale.
AC C
EP
TE D
310
13
ACCEPTED MANUSCRIPT The primary outcome measure was the difference in foot function index scale at week 1, week 4, and
325
follow-up at week 12 after randomization. Additionally, pressure pain thresholds (PPT) over the
326
affected gastrocnemii and soleus muscles and over the calcaneus were assessed. The simple main
327
effects analysis showed that the MFR group performed better than the control group in weeks 4 and
328
12 (P < 0.001). Patients in the MFR and control groups reported a 72.4% and7.4% reduction,
329
respectively, in their pain and functional disability in week 4, which persisted as 60.6% in the
330
follow-up at week 12 in the MFR group compared to the base-line. The mixed ANOVA revealed a
331
significant group-by-time interaction for changes in PPT over the gastrocnemii and soleus muscles,
332
and over the calcaneus compared to the control group (P < 0.05). The short term follow up was
333
mentioned as the major limitation of the study. The authors recommended future studies to compare
334
the MFR with established treatments like arch supports, self stretching or even with surgical
335
procedures.
M AN U
SC
RI PT
324
337
TE D
336
DISCUSSION
339
Nineteen RCTs covering 1,228 patients were included in this systematic review. The sample size
340
varied from 10 to 200 with an average of 65 (SD±44). The methodological qualities of the included
341
RCTs were moderate to high. Seventeen studies were with higher methodological quality and the
342
remaining 2 were of moderate quality, which is appreciable for a relatively new approach with
343
considerable amount of practice variations. The literature regarding the effectiveness of MFR was
344
mixed in both quality and results. The quality of the RCT studies varied greatly, some were more
345
substantial than others. The results of the studies were encouraging, particularly with the recently
346
published studies. In many RCT’s the MFR was adjunctive to other treatments and the potential-
347
specific MFR effect cannot be judged.
AC C
EP
338
14
ACCEPTED MANUSCRIPT Nine studies concluded that MFR may be better than no treatment or sham treatment for
349
various musculoskeletal and painful conditions. Seven studies demonstrated that MFR with a
350
conventional therapy is more effective than a control group receiving no treatment (3 studies), sham
351
treatment (1 study) or with a conventional therapy. Hanten and Chandler (1994) have found in their
352
study that, though MFR was effective in reducing hamstring tightness against a control group
353
receiving no treatment, the effect was inferior to a PNF treatment. Two other studies highlighted
354
MFR to be equally effective to conventional or “alternative” treatments (e.g., joint manipulation,
355
back school or hot packs). These data suggest that the MFR can be a useful adjunct to the
356
conventional therapies for various conditions.
M AN U
357
SC
RI PT
348
It seems reasonable that in the authors’ qualitative synthesis, the best evidence would be provided by
359
the higher quality studies, which are less likely to have biased results. Although the levels of
360
evidence in this review may be considered arbitrary, it seems unlikely that a different rating system
361
would have resulted in different conclusions. It has to be remembered in this situation that, generally
362
small sample sizes increase the possibility of type II error, where the likelihood of a study producing
363
a false negative result will be high. (Sim and Wright, 2000). Although attempts were made to find all
364
published RCTs, some relevant trials might have been overlooked. Due to resource and language
365
constraints, only English language publications were included in the review and no effort was made
366
to identify unpublished trials
EP
AC C
367
TE D
358
368
The included studies were very heterogeneous in terms of population included, type of MFR
369
administered, control groups, outcome measures, timing of follow-up, and presentation of data. Like
370
any other manual therapy interventions MFR also varies considerably in the technique, the pressure,
371
individual treatment times and overall number of treatment sessions. Until evidence is available on
372
the possible mechanism of action of MFR, or until different interventions have been compared 15
ACCEPTED MANUSCRIPT directly, there is no logical basis for choosing the optimal intervention. The experience and training
374
of the myofascial therapists who gave the treatments were mentioned in a few studies. No serious
375
adverse events were reported in the trials included in this review. Seven studies have reported minor
376
adverse events. The great variation in incidence of minor adverse events is probably due to different
377
definitions of adverse reaction, research designs or styles of MFR in the various studies.
RI PT
373
378
Some studies used a protocol of a fixed set of points for all patients while others used a flexible
380
protocol where the points were selected for each individual. Both methods are considered to be valid
381
and were analyzed together in this systematic review. There is evidence that MFR alone or added to
382
other conventional therapies, relieves pain and improves function not lesser than conventional
383
therapies studied. According to these results, MFR may be useful as either a unique therapy or as an
384
adjunct therapy to other established therapies for a variety of conditions like sub acute low back pain,
385
fibromyalgia, lateral epicondylitis, plantar fasciitis, headache, fatigue in breast cancer, pelvic
386
rotation, hamstring tightness etc. It is also noticeable that the magnitudes of the effects were mostly
387
restrained.
M AN U
TE D
388
SC
379
The experimental studies in this review can serve as a starting point for future research by
390
demonstrating the wide assortment of potential conditions that MFR may effectively treat. Although
391
a wide variety of conditions are being treated with MFR, it is important to have evidence to support
392
those actions. Anecdotal evidence is a good starting point, but it is time for scientific evidences on
393
MFR to support its clinical use.
AC C
EP
389
394 395
To attain the highest-quality evidences, good quality RCT designs should be utilized in the future
396
researches. Participants should be randomized, the design should be double blinded, and the clinician
397
performing the MFR should use it regularly in clinical practice. The subjective component of MFR 16
ACCEPTED MANUSCRIPT must be addressed in future study designs. Because of the nature of the technique, the effectiveness
399
of MFR can vary with the comfort level of the patient, so the patient and clinician should both feel at
400
ease around one another. Only one medical condition should be studied at a time, and MFR should
401
be used alone. As well, if possible, MFR should be compared with a control (no-treatment) group
402
and with other established treatments. These guidelines will result in higher-quality studies that can
403
help us determine the true effectiveness of MFR as a treatment for a wide variety of conditions.
404
CONCLUSIONS
405
The literature regarding the effectiveness of MFR was mixed in both quality and results. Although
406
the quality of the RCT studies varied greatly, the result of the studies was encouraging, particularly
407
with the recently published studies. MFR is emerging as a strategy with a solid evidence base and
408
tremendous potential. The studies in this review may serve as a good foundation for the future trials.
M AN U
SC
RI PT
398
409 410
412
REFERENCES
TE D
411
1. Ajimsha, M. S., 2011. Effectiveness of direct vs indirect technique myofascial release in
414
the management of tension-type headache. Journal of bodywork and movement
415
therapies, 15 (4), 431-435.
EP
413
2. Ajimsha, M. S., Chithra, S., & Thulasyammal, R. P., 2012. Effectiveness of myofascial
417
release in the management of lateral epicondylitis in computer professionals. Archives of
418
AC C
416
physical medicine and rehabilitation, 93 (4), 604-609.
419
3. Ajimsha, M. S., Daniel, B., & Chithra, S., 2014. “Effectiveness of Myofascial release in
420
the management of chronic low back pain in nursing professionals,” Journal of Bodywork
421
and Movement Therapies, 18, 273-281
17
ACCEPTED MANUSCRIPT 422
4. Ajimsha, M. S., Daniel, B., & Chithra, S., 2014. “Effectiveness of myofascial release in
423
the management of plantar heel pain: A randomized controlled trial”.The Foot;
424
http://dx.doi.org/10.1016/j.foot.2014.03.005 5. Arroyo-Morales, Manuel, et al., 2008 "Effects of myofascial release after high-intensity
426
exercise: a randomized clinical trial." Journal of manipulative and physiological
427
therapeutics 31(3); 217-223.
429
6. Barnes, J.F., 1990. Myofascial Release: the Search for Excellence, tenth ed. Rehabilitation Services Inc, Paoli, PA.
SC
428
RI PT
425
7. Barnes, M. F., 1997. Efficacy study of the effect of a myofascial release treatment
431
technique on obtaining pelvic symmetry. Journal of Bodywork and Movement
432
Therapies, 1(5), 289-296.
M AN U
430
8. Cantarero-Villanueva, Irene, et al., 2012. “Effectiveness of Core Stability Exercises and
434
Recovery Myofascial Release Massage on Fatigue in Breast Cancer Survivors: A
435
Randomized Controlled Clinical Trial,” Evidence-Based Complementary and Alternative
436
Medicine, vol. 2012, Article ID 620619, 9 pages, doi:10.1155/2012/620619
TE D
433
9. Castro-Sánchez, Adelaida María, et al., 2011. "Effects of myofascial release techniques
438
on pain, physical function, and postural stability in patients with fibromyalgia: a
439
randomized controlled trial." Clinical Rehabilitation 25 (9): 800-813.
AC C
EP
437
440
10. Castro-Sánchez, Adelaida María, et al., 2011. “Benefits of Massage-Myofascial Release
441
Therapy on Pain, Anxiety, Quality of Sleep, Depression, and Quality of Life in Patients
442 443
444 445
with Fibromyalgia,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 561753, 9 pages, doi:10.1155/2011/561753
11. Centre for Evidence-Based Physiotherapy, 2012. Physiotherapy evidence database (PEDro). http://www.pedro.org.au/. Accessed January 11, 2012. 18
ACCEPTED MANUSCRIPT 446
12. Day JA, Stecco C, Stecco A., 2009, Application of fascial manipulation technique in
447
chronic shoulder pain anatomical basis and clinical implications. J Bodyw Mov Ther.
448
13:128–35. 13. Fernández-Lao, Carolina, et al., 2012. "The influence of patient attitude toward massage
450
on pressure pain sensitivity and immune system after application of myofascial release in
451
breast cancer survivors: a randomized, controlled crossover study." Journal of
452
Manipulative and Physiological Therapeutics 35 (2): 94-100.
455 456
Medicine. April 2009. p. 28
SC
454
14. Glossary of Osteopathic Terminology". American Association of Colleges of Osteopathic
15. Greenman, P.E., 2003. Principles of Manual Medicine. Lippincott, Williams & Wilkins, Philadelphia, pp. 155-158
M AN U
453
RI PT
449
457
16. Hanten, W. P., & Chandler, S. D., 1994. Effects of myofascial release leg pull and sagittal
458
plane isometric contract-relax techniques on passive straight-leg raise angle. The Journal
459
of orthopaedic and sports physical therapy, 20(3), 138.
17. Hou, C.R., Tsai, L.C., Cheng, K.F., Chung, K.C., Hong, C.Z., 2002. Immediate effects of
461
various physical therapeutic modalities on cervical myofascial pain and trigger-point
462
sensitivity. Arch. Phys. Med. Rehabil. 83 (10), 1406-1414.
EP
464
18. Hsieh, Chang-Yu J., et al., 2002. "Effectiveness of four conservative treatments for subacute low back pain: a randomized clinical trial." Spine 27(11); 1142-1148
AC C
463
TE D
460
465
19. Huijing, P.O., Langevin, H.M., 2009. Communicating about fascia: history, pitfalls and
466
recommendations. International Journal of Therapeutic Massage and Bodywork 2 (4), 3-
467
8.
468
20. Kain, Jay, et al., 2011. "Comparison of an indirect tri-planar myofascial release (MFR)
469
technique and a hot pack for increasing range of motion." Journal of bodywork and
470
movement therapies 15(1): 63-67.
19
ACCEPTED MANUSCRIPT 471
21. Kalamir, Allan, et al., 2010. "Intra-oral myofascial therapy for chronic myogenous
472
temporomandibular disorders: a randomized, controlled pilot study." The Journal of
473
manual & manipulative therapy 18 (3): 139. 22. Khuman, P. Ratan, et al., 2013. Myofascial Release Technique in Chronic Lateral
475
Epicondylitis: A Randomized Controlled Study. International Journal of Health Sciences
476
and Research (IJHSR), 3(7), 45-52.
478
23. Kidd, R. F., 2009. Why myofascial release will never be evidence-based.International Musculoskeletal Medicine, 31(2), 55-56.
SC
477
RI PT
474
24. Kuhar, S., Subhash, K., & Chitra, J., 2007. Effectiveness of myofascial release in
480
treatment of plantar fasciitis: A rct. Indian Journal of Physiotherapy and Occupational
481
Therapy, 1(3), 3-9.
M AN U
479
25. Kuruma, Hironobu, et al., 2013. Effects of Myofascial Release and Stretching Technique
483
on Range of Motion and Reaction Time. Journal of Physical Therapy Science, 25(2),
484
169-171.
TE D
482
485
26. Langevin HM, Fox JR, Koptiuch C, Badger GJ, Greenan-Naumann AC, Bouffard NA, et
486
al.,2011, Reduced thoracolumbar fascia shear strain in human chronic low back pain.
487
BMC Musculoskelet Disord.12:203.
490 491
27. McKenney, K., Elder, A. S., Elder, C., & Hutchins, A., 2013. Myofascial Release as a
AC C
489
EP
488
Treatment for Orthopaedic Conditions: A Systematic Review. Journal of Athletic Training: Jul/Aug 2013, Vol. 48, No. 4, pp. 522-527.
492
28. Meltzer, K.R., Cao, T.V., Schad, J.F., King, H., Stoll, S.T., Standley, P.R., 2010. In vitro
493
modeling of repetitive motion injury and myofascial release. J. Bodyw. Mov. Ther. 14,
494
162-171.
20
ACCEPTED MANUSCRIPT 495 496
29. Myers, T.W., 2009. Anatomy Trains: Myofascial Meridians for Manual and Movement Therapists, second ed. Churchill Livingstone, Edinburgh. 30. Phillips B, Ball C, Sackett D, Badenoch D, Strauss S, Haynes B, et al., 2009. Oxford
498
Centre for Evidence-based Medicine Levels of Evidence (March 2009); available from
499
URL: http://www.cebm.net/?o=1025; Accessed March January 11, 2012.
500 501
RI PT
497
31. Pischinger, A., 1991. Matrix and Matrix Regulation: Basis for a Holistic Theory in Medicine. Haug International, Brussels.
32. Ramos-González, Elena, et al., 2012. "Comparative study on the effectiveness of
503
myofascial release manual therapy and physical therapy for venous insufficiency in
504
postmenopausal women." Complementary therapies in medicine20 (5): 291-298.
506
M AN U
505
SC
502
33. Schleip, R., 2003. Fascial plasticity–a new neurobiological explanation: Part 1. Journal of Bodywork and movement therapies, 7(1), 11-19.
34. Schleip, R., Chaitow, L., Findley, T.W., Huijing, P., 2012. Fascia -The Tensional
508
Network of the Human Body. The Science and Clinical Applications in Manual and
509
Movement Therapy. Elsevier, Edinburgh
512 513 514 515
Nomenclatures; Journal of Bodywork & Movement Therapies (2012) 16, 496-502
EP
511
35. Schleip R, Jager H & Klingler W., 2012. What is ‘fascia’? A review of different
36. Sim, J., & Wright, C., 2000. Research in health care: concepts, designs and methods.
AC C
510
TE D
507
Nelson Thornes.
37. Stecco A, Gesi M, Stecco C, Stern R., 2013, Fascial Components of the Myofascial Pain Syndrome; Curr Pain Headache Rep 17:352
516
38. Tozzi, Paolo, Davide Bongiorno, and Claudio Vitturini., 2011. "Fascial release effects on
517
patients with non-specific cervical or lumbar pain." Journal of Bodywork and Movement
518
Therapies 15 (4): 405-416.
519 21
ACCEPTED MANUSCRIPT 520
Figure 1. Study flow diagram.
521
Search Completed with Key words 522
RI PT
Myofascial Release, Myofascial Release Therapy, Randomized Controlled Trials
523 524 525 526
528
The
MEDLINE
CINAHL
Cochrane Library
529 530 531 532
M AN U
133 Articles
533 534 535 536
540 541 542 543 544 545 546 547
TE D
539
19 Articles
EP
538
Inclusion and Exclusion criteria Applied
AC C
537
Academic Search Premier
SC
527
Reviewed for level of
evidence
548 549 550 551 22
PEDro
Database
ACCEPTED MANUSCRIPT 552
Table 1. Physiotherapy Evidence Database (PEDro) Scale Scores 1. Eligibility criteria were specified (no points awarded) 2. Subjects were randomly allocated to groups 3. Allocation was concealed 4. The groups were similar at baseline regarding the most important prognostic indicators
RI PT
5. There was blinding of all subjects
6. There was blinding of all therapists who administered the therapy
7. There was blinding of all assessors who measured at least one key outcome
8. Measures of at least one key outcome were obtained from more than 85% of the subjects
SC
initially allocated to groups
9. All subjects for whom outcome measures were available received the treatment or control
M AN U
condition as allocated
10. The result of between-group comparisons are reported for at least one key outcome 11. The study provides both point measures and measures of variability for at least one key outcome 553 554
Level
Definition
TE D
Table 2. Centre of Evidence-Based Medicine: Levels of Evidence
Systematic reviews of randomized controlled trials
1b
Individual randomized controlled trial
1c
All-or-none studies
2a
Systematic reviews of cohort studies
2b
Individual cohort studies or low-quality randomized controlled trials
2c
Outcomes research
3a
Systematic reviews of case-control studies
3b
Individual case-control studies
4
Case series, poorly designed cohort or case-control studies
5
Animal and bench research, expert opinion
EP
1a
AC C
555
556 557 23
ACCEPTED MANUSCRIPT Table 3: Study results & grading included in the systematic review
Unilateral Pelvic Rotation
Hsieh CY 2002
Kuhar S 2007
ArroyoMorales 2008
Tozzi P 2010
Sub acute Low Back Pain
Plantar fasciitis
healthy active individuals
Supine rest x 5 min
10
MFR pelvic region, 10 min
Rest x 10 min
200
Back school program, MFR, joint manip or combined MFR + joint manip
30
Ultrasound x 5 min, contrast bath 20 in, exercises, MFR x 15 min
non-specific cervical(NP ) or lumbar pain (LBP)
120
Results
PEDr o Score
Single session
Passive hip flexion ROM
Post treatment gains PNF: 10.40 MFR: 6.60 Control: 0.90
6/10
2b
Single session
Pelvic Position
Better pelvic alignment post MFR
8/10
2b
VAS, Roland Morris activity scale
Back pain improved in all. No difference between groups
7/10
1b
FFI, VAS
Significant reduction in VAS and FFI
7/10
2b
HRV & BP
favors the recovery of HRV and diastolic BP after highintensity exercise
6/10
2b
7/10
2b
Back school :1/week x 3, MFR , joint manip & combined MFR + joint manip: 3/week x 3
NA
Ultrasoun d x 5 min, contrast bath 20 in, exercises
MFR x 40 min
sham treatment with disconnec ted ultrasound and magnetoth erapy x 40 min
NP: MFRx 6 min LBP: MFR x 12 Min
NP: Sham MFR x 6 Min LBP: Sham MFR x 12 in
62
Main Outcome Measures
Treatment Schedule
RI PT
Barnes MF 1997
75
MFR to leg x 10-15 min, Contractrelax PNF x 4 min
Control
SC
Hamstrings tightness
Treatment
Leve l of Evid ence (CE BM)
M AN U
Hanten WP 1994
Samp le Size
TE D
Condition
EP
First Author Year
AC C
558
24
10 consecutive days
Single session
Single session
dynamic ultrasound (US)
MFR improved fascial mobility& pain in people with non-specific NP or LBP.
ACCEPTED MANUSCRIPT
Ajimsha MS 2011
Fernánd ez-Lao 2012
Cantarer oVillanue va, I 2012
Fibromyalgi a
tension headache
Breast cancer
hot pack x 20 min
Single session
MFR x 90 min
Disconnec ted Maganeto therapy x 30 min
1 session/wee k x 20
VAS, STAI, BDI, PSQI
86
MFR x 60 min
sham shortwave and ultrasound treatment x 30 min
2 sessions/we ek x 20
number of tender points, MPQ and postural stability.
63
Direct MFR x 60 min Indirect MFR x 60 min
Slow soft stroking x 60 min
2 sessions/we ek x 12
numbers of days with headache
Neck and shoulder MFR x 40 min
Special attention & Education x 40 min
2 sessions separated by 2 weeks
20
Breast cancer
78
Multimoda l exercise and MFR x 90 min
ROM & Pain
usual care advises
25
3 sessions/we ek x 8
MFR alone or with selfcare is beneficial
8/10
2b
5/10
2b
7/10
1b
7/10
1b
MFR is effective than a control intervention
6/10
2b
Salivary flow rate, immunoglo bulin A (IgA) concentrati ons,
immediate increase in salivary flow rate & IgA
6/10
2b
POMS
multimodal program with MFR reduced fatigue, tension, depression, & improved vigor & muscle strength
7/10
2b
MFR is as effective as hot packs in increasing range of motion MFR improved pain & quality of life in patients with fibromyalgia MFR improved pain, sensory, and affective dimensions without change in postural stability
RI PT
SC
74
2 sessions/we ek x 5
M AN U
CastroSánchez , AM 2011
Fibromyalgi a
31
passive shoulder range of motion
Waist list
TE D
CastroSánchez , AM 2011
Healthy individual
indirect triplanar MFR x 3 min
EP
J. Kain 2011
30
MFR x 15 min, MFR 15 min with self care & exercises
AC C
Kalamir A 2010
chronic myogenous temporoman dibular disorders
ACCEPTED MANUSCRIPT
Kuruma H 2013
Chronic Lateral Epicondyliti s
80
specific back exercises (SBE) & MFR x 60 min
SBE & Sham MFR x 60 min
3 sessions/we ek x 8
40
30
MFR to hamstring x 8 Min. MFR to Quadriceps x 8 Min. stretch for quadriceps 8 min, MFR forearm x 30 min, Ultrasound x 5 min Stretching and strengtheni ng exercise
2b
PRTEE
MFR is effective for LE in Computer Professionals
7/10
Ib-
MPQ, QBPDS
MFR with SBE is effective for CLBP
7/10
1b
ROM, muscle stiffness, and Reaction Time
improved ROM & ease of movement
5/10
2b
pain, functional performanc e & grip strength
significant decrease in pain, improvement in functional performance & grip strength
7/10
2b
RI PT
MFR x 30 Min
3 sessions/we ek x 4
8/10
Lay supine x 8 min
Ultrasoun d x 5 min Stretching and strengthen ing exercise
Single session
3 sessions/we ek x 4
EP
Khuman PR 2013
Healthy individuals
68
sham ultrasound therapy x 30 min
Improvement in venous return blood flow, pain and quality of life noted
SC
Ajimsha MS 2014
10 weeks
65
blood pressure, venous velocity, skin temperatur e, pain
M AN U
Ajimsha MS 2012
Lateral Epicondyliti s (LE) in Computer Professional s chronic low back pain(CLBP) in nursing professional s
Venous return kinesiothe rapy 2 times daily
TE D
RamosGonzále z E 2012
venous insufficienc y in postmenopa usal women
MFR x 50 min x 2 session/we ek Venous return kinesiother apy 2 times daily
AC C
559 560 561 562 563 564
significant decrease in pain & sham plantar Ajimsha 3 functional MFR x 30 ultrasound MS 66 sessions/we FFI & PPT disability, 8/10 2b heel pain Min therapy x 2014 ek x 4 improvement (PHP) 30 min in pressure pain threshold Abbreviations: Myofascial Release (MFR), Not Applicable (NA), Range of Motion (ROM), State- Trait Anxiety Inventory (STAI), Beck Depression Inventory (BDI), Pittsburgh Quality of Sleep Index Questionnaire (PSQI), McGill Pain Questionnaire, (MPQ), Profile of Mood State (POMS) questionnaire, Quebec Back Pain Disability Scale (QBPDS), Chronic Low Back Pain (CLBP), Patient-Rated Tennis Elbow Evaluation (PRTEE). Minutes (Min), Manipulation (Manip), Center for Evidence-Based Medicine (CEBM), Proprioceptive Neuromuscular Facilitation (PNF), Visual Analogue Scale (VAS), Foot Function Index (FFI), Heart rate variability (HRV), Blood Pressure (BP), Foot function index (FFI), Pressure pain threshold (PPT).
565 566 26